1 Subjects: “...Biological Products / therapeutic use...”

2 Subjects: “...Biological Products / therapeutic use...”

3 “... associated side effects including drowsiness, dizziness and dry mouth; according to the product monograph...”

4 “... associated side effects including drowsiness, dizziness and dry mouth; according to the product monograph...”

5 “..., administration of blood product) in pre-hospital settings, and to examine clinical guidelines regarding the use...”

6 “..., administration of blood product) in pre-hospital settings, and to examine clinical guidelines regarding the use...”

7 “... or combination product of buprenorphine with naloxone (BUP-NAL) formulations for the treatment of OUD....”

8 “... or combination product of buprenorphine with naloxone (BUP-NAL) formulations for the treatment of OUD....”

9 “.... For instance, the combination product piperacillin-tazobactam is often referred to as monotherapy unless...”

10 “.... For instance, the combination product piperacillin-tazobactam is often referred to as monotherapy unless...”

11 “.... The production of methamphetamine is dangerous and produces large volumes of toxic chemical waste. In 2006...”

12 “.... The production of methamphetamine is dangerous and produces large volumes of toxic chemical waste. In 2006...”

13 “...The Eczema Society of Canada has a Seal of Acceptance program "where products are reviewed to earn...”

14 “...The Eczema Society of Canada has a Seal of Acceptance program "where products are reviewed to earn...”

15 “... products. These products use antimicrobial agents such as triclosan, chlorhexidine, iodophors or quaternary...”

16 “... products. These products use antimicrobial agents such as triclosan, chlorhexidine, iodophors or quaternary...”

17

18 “... to innovator INX, which could lead to patients being switched between products. The purpose of this report...”

19 “... to innovator INX, which could lead to patients being switched between products. The purpose of this report...”

20